Lately, HLA-G bearing EV (HLA-GEV) originated from liquid biopsies of blood samples derived from breast and ovarian cancer patients have been introduced as novel cancer biomarker (20, 21). This evidence concerns the gene HLA-G and ovarian carcinoma.